Overview Request Sample Pages Request Customization Download PDF
You are viewing: Italy Blood Collection Devices Market analysis

The Italy Blood Collection Devices Market was valued at $78 Million in 2025 and projected to reach to $109.5 Million by 2030, representing a compound annual growth rate of 7.0%. Italy's blood collection devices market is poised for steady expansion through 2030, supported by an aging demographic requiring frequent diagnostic testing and blood transfusions.

Italy Blood Collection Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Blood Collection Devices Market Trends and Insights

  • This steady expansion reflects Italy's robust healthcare infrastructure and increasing demand for advanced phlebotomy solutions across hospitals, diagnostic centers, and blood banks.
  • Italy's aging population and rising prevalence of chronic diseases are driving the adoption of safer, more efficient blood collection technologies. The Italian market benefits from strong regulatory frameworks and high healthcare spending, positioning Italy as a key player in Europe's blood collection devices sector.
  • Italy's emphasis on patient safety and infection control standards continues to fuel demand for innovative collection systems, including safety-engineered devices and integrated collection tubes.
  • Between 2025 and 2030, Italy is expected to see accelerated adoption of automated and point-of-care blood collection solutions, supported by investments in healthcare modernization and laboratory automation..

Key Market Statistics

  • CAGR (2025-2030) 7.0% CAGR
  • Market Size, 2025 ~USD 78 Million
  • Forecast, 2030 ~USD 109.5 Million
  • Country Italy

Italy Blood Collection Devices Market Overview

Market Valuation :

Italy's blood collection devices market is valued at $78.0 million in 2025, with a projected expansion to $109.5 million by 2030, demonstrating consistent market growth driven by healthcare modernization.

Aging Population Impact :

Italy's demographic shift toward an aging population is driving increased demand for blood collection and diagnostic services, creating sustained growth opportunities for phlebotomy device manufacturers and suppliers.

Healthcare Infrastructure :

Italy's robust healthcare system, including well-established hospitals, diagnostic centers, and blood banks, provides a stable foundation for adoption of advanced blood collection technologies and standardized phlebotomy practices.

Steady Growth Trajectory :

With a CAGR of 7.0% through 2030, Italy's market growth aligns closely with the global rate of 7.4%, indicating strong regional demand and competitive positioning within European healthcare markets.

Italy Blood Collection Devices Market Dynamics

  • The country's advanced healthcare infrastructure and emphasis on quality medical standards create favorable conditions for adoption of innovative phlebotomy solutions.
  • Healthcare facilities across Italy are increasingly investing in modern blood collection equipment to improve patient safety, reduce hemolysis rates, and enhance operational efficiency. The market will benefit from rising healthcare expenditures, regulatory compliance requirements, and growing awareness of infection control protocols.
  • Italian hospitals and diagnostic centers are prioritizing needle safety devices and integrated collection systems to meet EU directives.
  • Strategic partnerships between local distributors and international manufacturers will accelerate product penetration, while continued investment in blood banking infrastructure ensures sustained demand for specialized collection devices throughout the forecast period..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Italy's blood collection devices market is valued at $78.0 million in 2025 and will reach $109.5 million by 2030, growing at 7.0% CAGR.
      • Italy's aging demographic and rising chronic disease prevalence are primary drivers of demand for advanced blood collection technologies.
      • Italy's stringent healthcare regulations and high safety standards accelerate adoption of safety-engineered and automated collection devices.
      • Italy is positioned as a significant European market with strong potential for laboratory automation and point-of-care blood collection solutions.

      Blood Collection Devices Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment PLASMA/WHOLE BLOOD TUBES (Type)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment MANUAL BLOOD COLLECTION (Method)
      Market Size Base Year (Billions) ~USD 9.11 (2025)
      Revenue Forecast (Billions) ~USD 13.02 (2030)
      Segments Covered Product, Type, System Type, Method, Application, End User

      Italy Blood Collection Devices Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Blood Bags
      • Blood Collection Systems/ Monitors
      • Blood Collection Tubes
      • Lancets
      • Needle & Syringes

      By Type

      • Coagulation Tubes
      • Edta Tubes
      • Esr Tubes
      • Glucose Tubes
      • Heparin Tubes
      • Plasma/Whole Blood Tubes
      • Serum Tubes

      By System Type

      • Non-Vacuum Type
      • Vacuum Type

      By Method

      • Automated Blood Collection
      • Manual Blood Collection

      By Application

      • Diagnostic Applications
      • Therapeutic Applications

      By End User

      • Blood Banks
      • Diagnostic & Pathology Labs
      • Hospitals, Ambulatory Surgical Centers, And Nursing Homes
      • Other End Users

      ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BLOOD BANKS38.440.141.643.345.347.650.253.15
      DIAGNOSTIC & PATHOLOGY LABS51.754.857.760.964.668.873.6796.5
      HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES123.5132.2140.1149.1159.5171.2184.5199.57.3
      OTHER END USERS14.114.615.115.616.31717.918.84.5
      TOTAL227.7241.8254.5268.9285.7304.6326.1350.46.6

      Target Audience

      • Medical Device Manufacturers : Manufacturers need Italy-specific market data to develop localized product strategies, identify distribution partnerships, and allocate R&D resources for the Italian healthcare market.
      • Healthcare Facility Administrators : Hospital and diagnostic center leaders require market insights to benchmark procurement decisions, evaluate supplier options, and plan capital investments in blood collection infrastructure.
      • Distributors & Suppliers : Italian and European distributors need detailed market forecasts to optimize inventory management, identify growth segments, and develop targeted sales strategies for healthcare facilities.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Italy's healthcare sector need comprehensive market analysis to assess growth potential, competitive dynamics, and return on investment in medical device companies.
      • Healthcare Consultants & Analysts : Consultants advising healthcare organizations and industry stakeholders require Italy-specific data to support strategic recommendations, market assessments, and competitive intelligence reports.

      Key Companies in the Italy Blood Collection Devices Market

      CompanyHQOwnershipStrongest segments
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions,
      ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula),
      NOLATOSwedenPublic CompanyMedical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC),
      QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables),
      GRIFOLS, S.A.SpainPublic CompanyBiopharma (plasma-derived medicines),Diagnostic,Bio Supplies,
      NIPRO CORPORATIONJapanPublic CompanyRenal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components),
      HAEMONETICS CORPORATIONUnited StatesPublic CompanyPlasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware,
      CARDINAL HEALTHUnited StatesPublic CompanyBranded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands),
      RETRACTABLE TECHNOLOGIES, INC.United StatesPublic CompanyVanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps,
      AB MEDICAL CO., LTD.IrelandPublic CompanyCardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio,

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

      ABBOTT LABORATORIES

      Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.

      NOLATO

      Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.

      QIAGEN NV

      QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.

      GRIFOLS, S.A.

      Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.

      NIPRO CORPORATION

      Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.

      HAEMONETICS CORPORATION

      Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.

      ICU MEDICAL, INC.

      ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.

      CARDINAL HEALTH

      Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.

      RETRACTABLE TECHNOLOGIES, INC.

      Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.

      AB MEDICAL CO., LTD.

      AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.

      Reasons to Buy this Report

      • Precise Italy Market Data : Access detailed market sizing and forecasts specific to Italy's blood collection devices sector, enabling accurate business planning and investment decisions tailored to the Italian healthcare landscape.
      • Competitive Positioning : Understand Italy's market dynamics relative to global trends, identify competitive gaps, and benchmark your offerings against regional standards to optimize market entry or expansion strategies.
      • Growth Opportunity Assessment : Leverage Italy-specific CAGR data and demographic insights to identify high-potential segments within hospitals, diagnostic centers, and blood banks for targeted product development and marketing.
      • Regulatory & Infrastructure Insights : Gain intelligence on Italy's healthcare infrastructure, compliance requirements, and adoption patterns to navigate market entry barriers and align products with local healthcare standards.
      • Strategic Decision Support : Make informed decisions on market investment, partnership development, and resource allocation in Italy based on comprehensive market analysis and forward-looking forecasts through 2030.

      Frequently asked questions

      What is the current market size of blood collection devices in Italy?

      Italy's blood collection devices market is valued at $78.0 million in 2025.

      What is the projected market size for blood collection devices in Italy by 2030?

      Italy's blood collection devices market is projected to reach $109.5 million by 2030.

      What is the growth rate of Italy's blood collection devices market?

      Italy's blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2030.

      What factors are driving growth in Italy's blood collection devices market?

      Key drivers include Italy's aging population, rising prevalence of chronic diseases, stringent safety regulations, and investments in healthcare modernization and laboratory automation.

      Which blood collection device types are gaining traction in Italy?

      Safety-engineered devices, integrated collection tubes, automated collection systems, and point-of-care blood collection solutions are experiencing increased adoption in Italy.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      The following is a breakdown of the primary respondents:

      Blood Collection Devices Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Blood Collection Devices Market

      Data Triangulation

      The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.

      Stakeholders

      • Healthcare Service Providers (Hospitals and Pathology Centers)
      • Blood Collection Product Manufacturers
      • Blood Banks
      • Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
      • To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
      • To profile the key players in the market and comprehensively analyze their market positions and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market

       

      Get the Full Blood Collection Devices Market Report

      Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status